{"article":{"annotation":{"article_id":"uk-clinical-research-delivery-kpis-september-2026","available_at":"2026-10-21T11:12:14.205598Z","geography_revision":"ef6ee0010dda5fe7b240fd514749b43e214c57da73222d2e40ec83b276dd0977","id":"caaacf69285bada66a2ad9c576af7702e3830baa6489aa3af521374e7e176aa5","input_sha256":"e8014d0d0a7d1fbbba77dcf0c4c558f3ab7116072107df04a51ad0b9d33774bf","limitations":["Rule-derived subjects are candidates, not verified editorial labels or calibrated model probabilities.","Coverage is distinct from event location. Unknown country/city/coordinates remain absent; no automatic geocoding.","Article geometries keep their stated precision and methodology; reproducing them is not independent coordinate verification."],"method":"controlled-rules-v1","places":[{"admin1":null,"city":null,"coordinate_note":null,"coordinate_reference_system":"OGC:CRS84","coordinate_source":null,"country":"GB","evidence":[{"field":"country","language":"en","note":"Explicit preserved editorial country/region; no city or national centroid inferred","source_urls":["https://www.gov.uk/government/statistics/uk-clinical-research-delivery-key-performance-indicators-data-to-september-2026/uk-clinical-research-delivery-key-performance-indicators-data-to-september-2026"]}],"geometry":null,"id":"iso3166-1:GB","kind":"country-or-area","labels":{"ar":"المملكة المتحدة لبريطانيا العظمى وآيرلندا الشمالية","en":"United Kingdom of Great Britain and Northern Ireland","es":"Reino Unido de Gran Bretaña e Irlanda del Norte","fr":"Royaume-Uni de Grande-Bretagne et d’Irlande du Nord"},"match_status":"candidate","precision":"regional","role":"coverage","uncertainty_m":null}],"rules_sha256":"fb5ad3c27c91cb840f7a0a05f7f64a5cb26ad0374409ff9457f277c7092e22b4","schema_version":1,"subjects":[{"concept_id":"medtop:07000000","confidence":null,"confidence_method":null,"evidence":[{"field":"category+topics","language":"en","note":"Preserved editorial category/topic; broad candidate only","source_urls":["https://www.gov.uk/government/statistics/uk-clinical-research-delivery-key-performance-indicators-data-to-september-2026/uk-clinical-research-delivery-key-performance-indicators-data-to-september-2026"]}],"method":"controlled-rules-v1","rule_id":"health-broad","status":"candidate"}],"taxonomy_revision":"1f2db31d811fca07e99b16d402c10e2cc2965c9df1c7b41d9be348b40a24e7fb","taxonomy_version":"IPTC Media Topics 2026-Q2"},"api_url":"https://newsverum.com/api/v1/articles/uk-clinical-research-delivery-kpis-september-2026?lang=de","category":"health","content":{"key_points":[],"paragraphs":["In den am 21. Oktober vom Ministerium für Gesundheit und Soziales veröffentlichten UK-Clinical-Research-Delivery-Kennzahlen waren im September 2026 82 Prozent der offenen Studien bei Rekrutierung nach Zeitplan und Ziel unterwegs; der Zielwert lag bei 80 Prozent. Im selben Monat hielten 100 Prozent der gemeinsamen behördlichen Prüfungen von Arzneimittelstudien die Frist ein, gegenüber einem Ziel von 99 Prozent.","Dagegen hatten im März 2026 52 Prozent der Studien innerhalb von 60 Tagen nach behördlicher Genehmigung die Rekrutierung eröffnet; 61 Prozent gewannen innerhalb von 30 Tagen nach Öffnung die erste teilnehmende Person. Beide Zielwerte lagen bei 90 Prozent. Die Bezugsmonate unterscheiden sich je Kennzahl. Der Bericht umfasst eine definierte Studiengruppe im zentralen Portfolioverwaltungssystem, nicht das gesamte britische Forschungssystem; jüngste Werte können revidiert werden."],"sections":[]},"corrections":[],"country":"GB","data":{"blocks":[{"columns":[{"key":"measure","label":{"ar":"المؤشر","de":"Indikator","en":"Indicator","es":"Indicador","fr":"Indicateur","pt":"Indicador","tr":"Gösterge"},"type":"text"},{"key":"period","label":{"ar":"الفترة المرجعية","de":"Bezugszeitraum","en":"Reference period","es":"Periodo de referencia","fr":"Période de référence","pt":"Período de referência","tr":"Referans dönemi"},"type":"text"},{"key":"actual","label":{"ar":"النسبة المنشورة","de":"Gemeldete Quote","en":"Reported rate","es":"Tasa publicada","fr":"Taux publié","pt":"Taxa publicada","tr":"Gerçekleşen oran"},"type":"number","unit":"percent"},{"key":"target","label":{"ar":"الهدف","de":"Ziel","en":"Target","es":"Objetivo","fr":"Objectif","pt":"Meta","tr":"Hedef"},"type":"number","unit":"percent"}],"description":{"ar":"أحدث الفترات المنشورة وأهداف أربعة مؤشرات لبرنامج تسليم الأبحاث السريرية البريطاني.","de":"Zuletzt gemeldete Zeiträume und Ziele für vier UK-Clinical-Research-Delivery-Kennzahlen.","en":"Latest reported periods and targets for four UK Clinical Research Delivery indicators.","es":"Últimos periodos publicados y metas de cuatro indicadores UK Clinical Research Delivery.","fr":"Dernières périodes publiées et objectifs de quatre indicateurs UK Clinical Research Delivery.","pt":"Períodos mais recentes e metas de quatro indicadores UK Clinical Research Delivery.","tr":"Dört UK Clinical Research Delivery göstergesinin son raporlanan dönemleri ve hedefleri."},"id":"clinical-research-performance-kpis","methodology":{"ar":"نُقلت النسب من جداول المؤشرات ذات الصلة؛ ويختلف شهر المرجع بين الصفوف.","de":"Die gemeldeten Quoten stammen aus den jeweiligen Kennzahlentabellen; der Bezugsmonat variiert je Zeile.","en":"Reported rates are taken from the corresponding indicator tables; the reference month varies by row.","es":"Las tasas proceden de las tablas correspondientes; el mes de referencia varía por fila.","fr":"Les taux publiés proviennent des tableaux correspondants ; le mois de référence varie selon la ligne.","pt":"As taxas foram retiradas das tabelas correspondentes; o mês de referência varia por linha.","tr":"Gerçekleşen oranlar ilgili göstergeye ait kaynak tablolarından aktarılmıştır; referans ayı satırlara göre değişir."},"rowTranslations":[{"measure":{"ar":"دراسات مفتوحة تسير وفق وقت التجنيد وهدفه","de":"Offene Studien im Zeit- und Rekrutierungsziel","en":"Open studies on track for recruitment to time and target","es":"Estudios abiertos según calendario y objetivo de reclutamiento","fr":"Études ouvertes respectant calendrier et objectif de recrutement","pt":"Estudos abertos dentro do prazo e da meta de recrutamento","tr":"Alımı süre ve hedefe göre sürdüren açık çalışmalar"},"period":{"ar":"سبتمبر 2026","de":"September 2026","en":"September 2026","es":"Septiembre de 2026","fr":"Septembre 2026","pt":"Setembro de 2026","tr":"Eylül 2026"}},{"measure":{"ar":"دراسات المنتجات الطبية التي أكملت المراجعة الموحدة في الوقت المحدد","de":"Arzneimittelstudien mit fristgerechter gemeinsamer Prüfung","en":"Medicinal-product studies completing timely combined review","es":"Estudios de medicamentos que completan la revisión conjunta a tiempo","fr":"Études de médicaments achevant l’examen combiné dans les délais","pt":"Estudos de medicamentos com análise conjunta concluída no prazo","tr":"Birleşik düzenleyici incelemeyi zamanında tamamlayan ilaç çalışmaları"},"period":{"ar":"سبتمبر 2026","de":"September 2026","en":"September 2026","es":"Septiembre de 2026","fr":"Septembre 2026","pt":"Setembro de 2026","tr":"Eylül 2026"}},{"measure":{"ar":"الدراسات التي فُتحت للتجنيد خلال 60 يوماً من الموافقة","de":"Studien, die innerhalb von 60 Tagen nach Genehmigung für die Rekrutierung geöffnet wurden","en":"Studies opened to recruitment within 60 days of approval","es":"Estudios abiertos al reclutamiento en los 60 días posteriores a la aprobación","fr":"Études ouvertes au recrutement dans les 60 jours suivant l’approbation","pt":"Estudos abertos ao recrutamento em até 60 dias após a aprovação","tr":"Onaydan sonraki 60 gün içinde alıma açılan çalışmalar"},"period":{"ar":"مارس 2026","de":"März 2026","en":"March 2026","es":"Marzo de 2026","fr":"Mars 2026","pt":"Março de 2026","tr":"Mart 2026"}},{"measure":{"ar":"أول مشارك جُنّد خلال 30 يوماً من الموافقة","de":"Erste teilnehmende Person innerhalb von 30 Tagen nach Genehmigung aufgenommen","en":"First participant recruited within 30 days of approval","es":"Primer participante reclutado en los 30 días posteriores a la aprobación","fr":"Premier participant recruté dans les 30 jours suivant l’approbation","pt":"Primeiro participante recrutado em até 30 dias após a aprovação","tr":"Onaydan sonraki 30 gün içinde çalışmaya alınan ilk katılımcı"},"period":{"ar":"مارس 2026","de":"März 2026","en":"March 2026","es":"Marzo de 2026","fr":"Mars 2026","pt":"Março de 2026","tr":"Mart 2026"}}],"rows":[{"actual":82,"measure":"Open studies on track for recruitment to time and target","period":"September 2026","target":80},{"actual":100,"measure":"Medicinal-product studies completing timely combined review","period":"September 2026","target":99},{"actual":52,"measure":"Studies opened to recruitment within 60 days of approval","period":"March 2026","target":90},{"actual":61,"measure":"First participant recruited within 30 days of approval","period":"March 2026","target":90}],"sourceUrls":["https://www.gov.uk/government/statistics/uk-clinical-research-delivery-key-performance-indicators-data-to-september-2026/uk-clinical-research-delivery-key-performance-indicators-data-to-september-2026"],"title":{"ar":"مؤشرات أداء الأبحاث السريرية","de":"Kennzahlen zur klinischen Forschung","en":"Clinical research performance indicators","es":"Indicadores de investigación clínica","fr":"Indicateurs de performance de la recherche clinique","pt":"Indicadores de investigação clínica","tr":"Klinik araştırma performans göstergeleri"},"type":"table","updatedAt":"2026-10-21T10:55:52Z"}],"version":1},"data_downloads":[{"formats":{"csv":"https://newsverum.com/api/v1/articles/uk-clinical-research-delivery-kpis-september-2026/data/clinical-research-performance-kpis?lang=de&format=csv","json":"https://newsverum.com/api/v1/articles/uk-clinical-research-delivery-kpis-september-2026/data/clinical-research-performance-kpis?lang=de&format=json"},"id":"clinical-research-performance-kpis"}],"data_types":["table"],"editorial_illustration":{"alt":"Konzeptionelle Darstellung von öffentlicher Gesundheit, Forschung und vernetzten Daten.","asset_id":"newsverum-v1-health","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.avif","width":1536}],"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"de","scope":"topic","url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","width":1536}],"width":1536},"event_id":"event-b3c04845-7429-5bd6-93e2-f4f695e5493b","event_period":"2026-09","event_period_basis":"event-or-reference-period","id":"uk-clinical-research-delivery-kpis-september-2026","image":null,"importance":0.6,"language":"de","modified_at":"2026-10-21T11:11:49+00:00","publication_basis":"publication-record","published_at":"2026-10-21T11:11:49+00:00","reading_minutes":1,"region":"world","section_illustration":{"alt":"Konzeptionelle Darstellung von öffentlicher Gesundheit, Forschung und vernetzten Daten.","asset_id":"newsverum-v1-health","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.avif","width":1536}],"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"de","scope":"section","url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","width":1536}],"width":1536},"slug":"uk-clinical-research-delivery-kpis-september-2026","sources":[{"checkedAt":"2026-10-21","name":"Department of Health and Social Care","publishedAt":"2026-10-21","url":"https://www.gov.uk/government/statistics/uk-clinical-research-delivery-key-performance-indicators-data-to-september-2026/uk-clinical-research-delivery-key-performance-indicators-data-to-september-2026"}],"summary":"Der Bericht zeigt einige Erfüllungsindikatoren über Ziel, während Studienöffnung und Rekrutierung darunter blieben.","text":"Der Bericht zeigt einige Erfüllungsindikatoren über Ziel, während Studienöffnung und Rekrutierung darunter blieben.\n\nIn den am 21. Oktober vom Ministerium für Gesundheit und Soziales veröffentlichten UK-Clinical-Research-Delivery-Kennzahlen waren im September 2026 82 Prozent der offenen Studien bei Rekrutierung nach Zeitplan und Ziel unterwegs; der Zielwert lag bei 80 Prozent. Im selben Monat hielten 100 Prozent der gemeinsamen behördlichen Prüfungen von Arzneimittelstudien die Frist ein, gegenüber einem Ziel von 99 Prozent.\n\nDagegen hatten im März 2026 52 Prozent der Studien innerhalb von 60 Tagen nach behördlicher Genehmigung die Rekrutierung eröffnet; 61 Prozent gewannen innerhalb von 30 Tagen nach Öffnung die erste teilnehmende Person. Beide Zielwerte lagen bei 90 Prozent. Die Bezugsmonate unterscheiden sich je Kennzahl. Der Bericht umfasst eine definierte Studiengruppe im zentralen Portfolioverwaltungssystem, nicht das gesamte britische Forschungssystem; jüngste Werte können revidiert werden.","title":"82 Prozent der offenen klinischen Studien im Vereinigten Königreich lagen im September im Plan","topics":[],"translations":[{"api_url":"https://newsverum.com/api/v1/articles/uk-clinical-research-delivery-kpis-september-2026?lang=tr","language":"tr","url":"https://newsverum.com/tr/news/uk-clinical-research-delivery-kpis-september-2026"},{"api_url":"https://newsverum.com/api/v1/articles/uk-clinical-research-delivery-kpis-september-2026?lang=en","language":"en","url":"https://newsverum.com/en/news/uk-clinical-research-delivery-kpis-september-2026"},{"api_url":"https://newsverum.com/api/v1/articles/uk-clinical-research-delivery-kpis-september-2026?lang=ar","language":"ar","url":"https://newsverum.com/ar/news/uk-clinical-research-delivery-kpis-september-2026"},{"api_url":"https://newsverum.com/api/v1/articles/uk-clinical-research-delivery-kpis-september-2026?lang=fr","language":"fr","url":"https://newsverum.com/fr/news/uk-clinical-research-delivery-kpis-september-2026"},{"api_url":"https://newsverum.com/api/v1/articles/uk-clinical-research-delivery-kpis-september-2026?lang=es","language":"es","url":"https://newsverum.com/es/news/uk-clinical-research-delivery-kpis-september-2026"},{"api_url":"https://newsverum.com/api/v1/articles/uk-clinical-research-delivery-kpis-september-2026?lang=de","language":"de","url":"https://newsverum.com/de/news/uk-clinical-research-delivery-kpis-september-2026"},{"api_url":"https://newsverum.com/api/v1/articles/uk-clinical-research-delivery-kpis-september-2026?lang=pt","language":"pt","url":"https://newsverum.com/pt/news/uk-clinical-research-delivery-kpis-september-2026"}],"url":"https://newsverum.com/de/news/uk-clinical-research-delivery-kpis-september-2026"},"version":"1"}